Latest filing published 05 Apr 2022 for Zymergen Inc., €64k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Aaron Kimball: trading record in brief
Aaron Kimball appears in our data through filings on Zymergen Inc. shares, published by SEC (Form 4). In total, 8 filings cover trades dated from 6 October 2021 to 1 April 2022.
No open-market purchase appears, only 5 sales worth €509k. Other entries cover 1 share grant and 1 option exercise. In 2022 alone, the filings show no purchases and 5 sales.
The latest filing, published on 5 April 2022, reports an open-market sale of €20k in Zymergen Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Aaron Kimball
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,000 shares@ US$2.842912.3% of flowCommon StockSEC:0001645842-22-000052:0
- 25,000 shares@ US$3.813816.2% of flowCommon StockSEC:0001645842-22-000028:0
- 25,000 shares@ US$5.064221.5% of flowCommon StockSEC:0001645842-22-000013:0
- 50,000 shares@ US$5.181643.3% of flowCommon StockSEC:0001645842-22-000007:0
- 5,000 shares0Common StockSEC:0001645842-21-000042:0
- 85,000 shares0Common StockSEC:0001645842-21-000025:0
- 9,000 shares@ US$4.476.6% of flowCommon StockSEC:0001645842-21-000020:0
7 of 7 declarations
